In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.

In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.

INTRODUCTION: Trastuzumab, a humanized antibody directed against the Her2 receptor, induces the expression of p27(kip1), an intranuclear cyclin-dependent kinase inhibitor in some breast cancer cells. The aim of this study was to develop a radioimmunoconjugate (RIC) to monitor trastuzumab-induced p27...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Cornelissen, B, Kersemans, V, McLarty, K, Tran, L, Vallis, K, Reilly, R
Ձևաչափ:	Journal article
Լեզու:	English
Հրապարակվել է:	2009

Նմանատիպ նյութեր

The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).
‌: Cornelissen, B, և այլն
Հրապարակվել է: (2008)

111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.
‌: Cornelissen, B, և այլն
Հրապարակվել է: (2009)

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
‌: McLarty, K, և այլն
Հրապարակվել է: (2009)

Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate.
‌: Costantini, D, և այլն
Հրապարակվել է: (2008)

Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts.
‌: Costantini, D, և այլն
Հրապարակվել է: (2010)

(111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer.
‌: Costantini, D, և այլն
Հրապարակվել է: (2007)

Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin)
‌: Caroline Chung, և այլն
Հրապարակվել է: (2009-01-01)

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
‌: McLarty, K, և այլն
Հրապարակվել է: (2009)

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer
‌: Caroline Muñoz, և այլն
Հրապարակվել է: (2024-03-01)

Chemotherapy-induced cardiotoxic effect in breast cancer patients treated with trastuzumab (Herceptin) by MRI
‌: Mohamed Aboulfotouh Mourad, և այլն
Հրապարակվել է: (2023-12-01)

Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection.
‌: Cornelissen, B, և այլն
Հրապարակվել է: (2008)

Biodistribution and nuclear import of 111In-labeled HIV-1 tat peptide immunoconjugates after intravenous or intratumoural injection in tumour-bearing mice
‌: Cornelissen, B, և այլն
Հրապարակվել է: (2006)

The importance of antibody dependent cell-mediated cytotoxicity (ADCC) for breast cancer response to trastuzumab - Herceptin
‌: Juranić Zorica D., և այլն
Հրապարակվել է: (2002-01-01)

Recommendations for Management of the Trastuzumab (Herceptin) among Iranian Breast Cancer Patients, A Policy Brief
‌: Mohammad Reza Rouhollahi, և այլն
Հրապարակվել է: (2014-04-01)

Validation of ELISA Test-system for Trastuzumab (Herceptin, Hertikad) quantitative determination in biological fluids
‌: V. V. Pisarev, և այլն
Հրապարակվել է: (2023-05-01)

Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis
‌: Florence R. Wilson, և այլն
Հրապարակվել է: (2018-11-01)

Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
‌: Brunet Joan, և այլն
Հրապարակվել է: (2007-05-01)

Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.
‌: Cornelissen, B, և այլն
Հրապարակվել է: (2007)

Kinetics of internalization and nuclear import and efflux of 111In-and 123I-labeled HIV-1 tat-peptide immunoconjugates (IC's) in BT-474 human breast cancer cells
‌: Cornelissen, B, և այլն
Հրապարակվել է: (2006)

In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin
‌: Soudabeh Akbarzadeh-Sharbaf, և այլն
Հրապարակվել է: (2012-01-01)

Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
‌: Florence R. Wilson, և այլն
Հրապարակվել է: (2017-10-01)

Plant-made trastuzumab (herceptin) inhibits HER2/Neu+ cell proliferation and retards tumor growth.
‌: Tatiana V Komarova, և այլն
Հրապարակվել է: (2011-01-01)

Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice
‌: Yousif Nasser, և այլն
Հրապարակվել է: (2011-10-01)

Prática de clínica dos enfermeiros portugueses: administração subcutânea de trastuzumab (herceptin®) e rituximab (mabthera®)
‌: Alice Monteiro, և այլն
Հրապարակվել է: (2018-06-01)

A preliminary study to establish the transfected CHO cell lines which highly express Trastuzumab - A biosimilar product of Herceptin
‌: Nguyen Quang Huy, և այլն
Հրապարակվել է: (2022-11-01)

A model system to explore the detection limits of antibody-based immuno-SPECT imaging of exclusively intranuclear epitopes
‌: Veal, M, և այլն
Հրապարակվել է: (2021)

Ultrasound-triggered herceptin liposomes for breast cancer therapy
‌: Amal Elamir, և այլն
Հրապարակվել է: (2021-04-01)

Effect of recombinant Herceptin on the growth of breast cancer cells
‌: Nafiseh Kiarostami, և այլն
Հրապարակվել է: (2019-06-01)

Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
‌: Volkmar Müller, և այլն
Հրապարակվել է: (2018-03-01)

Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
‌: Kong Sun-Young, և այլն
Հրապարակվել է: (2008-10-01)

Herceptin resistance in HER2-moderately expressed breast cancer
‌: Kerry, J, և այլն
Հրապարակվել է: (2012)

Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
‌: Costantini, D, և այլն
Հրապարակվել է: (2010)

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.
‌: Fredersdorf, S, և այլն
Հրապարակվել է: (1997)

Cell penetrating peptides for in vivo molecular imaging applications.
‌: Kersemans, V, և այլն
Հրապարակվել է: (2008)

Regulation of p27<sup>Kip1</sup> and p57<sup>Kip2</sup> Functions by Natural Polyphenols
‌: Gian Luigi Russo, և այլն
Հրապարակվել է: (2020-09-01)

Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Randomized Controlled Trial
‌: Naveen Reddy, և այլն
Հրապարակվել է: (2024-03-01)

An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
‌: Qing Chen, և այլն
Հրապարակվել է: (2017-01-01)

Screening For Small Molecule Inhibitors Of p27Kip1 Degradation
‌: Ooi, Li Ching
Հրապարակվել է: (2012)

p27KIP1 Deletions in Childhood Acute Lymphoblastic Leukemia
‌: Hiroaki Komuro, և այլն
Հրապարակվել է: (1999-08-01)

p27kip1 at the crossroad between actin and microtubule dynamics
‌: Gian Luca Rampioni Vinciguerra, և այլն
Հրապարակվել է: (2019-04-01)